Table of contents

Clinical and epidemiological research

• Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey (7 September, 2018)

  Nadia M T Roodenrijs, Maria J H de Hair, Marlies C van der Goes, Johannes W G Jacobs, Paco M J Welsing, Désirée van der Heijde, Daniel Aletaha, Maxime Dougados, Kimme L Hyrich, Iain B McInnes, Ulf Mueller-Ladner, Ladislav Senolt, Zoltan Szekanecz, Jacob M van Laar, György Nagy, On behalf of the whole EULAR Task Force on development of EULAR recommendations for the comprehensive management of difficult-to-treat rheumatoid arthritis
• Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials (29 September, 2018)

  Nicolino Ruperto, Hermine I Brunner, Pierre Quartier, Tamàs Constantin, Nico M Wulffraat, Gerd Horneff, Ozgur Kasapcopur, Rayfel Schneider, Jordi Anton, Judith Barash, Reinhard Berner, Fabrizia Corona, Ruben Cuttica, Marine Fouillet-desjonqueres, Michel Fischbach, Helen E Foster, Dirk Foell, Sebastião C Radominski, Athimalaipet V Ramanan, Ralf Trauzeddel, Erbil Unsal, Jérémy Levy, Eleni Vritzali, Alberto Martini, Daniel J Lovell, On behalf of the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG)
• Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial (2 October, 2018) Free

  Yuko Kaneko, Hideto Kameda, Kei Ikeda, Tomonoti Ishii, Kosaku Murakami, Hyota Takamatsu, Yoshiya Tanaka, Takayuki Abe, Tsutomu Takeuchi
• Reliability of a consensus-based ultrasound definition and scoring for enthesitis in spondyloarthritis and psoriatic arthritis: an OMERACT US initiative (3 August, 2018)

  Peter V Balint, Lene Terslev, Philippe Aegerter, George Arthur Willem Bruyn, Isabelle Chary-Valckenaere, Frederique Gandjbakhch, Annamaria Iagnocco, Sandrine Jousse-Joulin, Ingrid Möller, Esperanza Naredo, Wolfgang A Schmidt, Richard J Wakefield, Maria-Antonietta D’Agostino
• Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints? (20 September, 2018)

  Brigitte Michelsen, Joseph Sexton, Josef S Smolen, Daniel Aletaha, Niels Steen Krogh, Désirée van der Heijde, Tore K Kvien, Merete Lund Hetland
• Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus (8 October, 2018)

  Julie Barsalou, Nathalie Costedoat-Chalumeau, Adey Berhanu, Cesar Fors-Nieves, Ummara Shah, Patrick Brown, Carl A Laskin, Nathalie Morel, Kateri Levesque, Jill P Buyon, Earl D Silverman, Peter M Izmirly
• Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study (8 October, 2018)

  Richard James Partington, Sara Muller, Toby Helliwell, Christian D Mallen, Alyshah Abdul Sultan
• Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial (3 October, 2018)

  Margreet Kloppenburg, Roberta Ramonda, Klaus Bobacz, Wing-Yee Kwok, Dirk Elewaut, Tom W J Huizinga, Féline P B Kroon, Leonardo Punzi, Josef S Smolen, Bert Vander Cruyssen, Ron Wolterbeek, Gust Verbruggen, Ruth Wittoek